Advertisement

Topics

Search Results for "Wockhardt Europe Ltd"

20:01 EST 20th November 2017 | BioPortfolio

Matching Channels

Sweden

The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Amyloidosis

AA amyloidosis affects approximately 35,000 - 50,000 individuals in the United States, Europe (Top 5 countries) and Japan. The disease occurs in a subset of patients with long-lasting inflammatory c...

OncoDEEP

At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Phoenix MarCom

Phoenix MarCom is a specialist marketing communications company, working with clients in the clean tech (including renewables, environmental technology, low carbon and sustainability), scientific an...

Matching News

Allergy eye drops from Wockhardt win FDA nod

The FDA has approved Wockhardt's eye drops for ophthalmic allergies.  -More- 

Wockhardt's Antibiotic Injection Gets U.S. FDA Approval

  Life Sciences Jobs   ...

Wockhardt Ltd WOCKPHARMA Financial and Strategic SWOT Analysis Review [Report Updated: 01082017] Prices from USD $125

Wockhardt Ltd WOCKPHARMA Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by Glob...

Wockhardt Ltd WOCKPHARMA Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryWockhardt Ltd Wockhardt is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant biopharmaceutical formulations. The...

Wockhardt Ltd WOCKPHARMA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryWockhardt Ltd Wockhardt is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant biopharmaceutical formulations. The...

Wockhardt Ltd WOCKPHARMA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25102017] Prices from USD $250

SummaryWockhardt Ltd Wockhardt is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant biopharmaceutical formulations. The...

Global and Regional Cephalosporin Market Research Report 2017 [Report Updated: 07112017] Prices from USD $3500

Summary Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.Cephalosporin originally derived from the fungus Acremonium, which was previously k...

Global Cephalosporin Market Research Report 20112023 [Report Updated: 19092017] Prices from USD $3250

Summary Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.Cephalosporin originally derived from the fungus Acremonium, which was previously k...

Matching PubMed Articles

Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP).

Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using differe...

E-WIN Project 2016: Evaluating the current gender situation in neurosurgery across Europe. An interactive, multiple-level Survey.

The proportion of females among neurosurgeons appears to be growing worldwide with time. Official data concerning the current situation across Europe have not yet been published. Thus, there are still...

Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE.

Are there any changes in the treatments involving ART and IUI initiated in Europe during 2013 compared with previous years?

CardioScape mapping the cardiovascular funding landscape in Europe.

The burden of cardiovascular disease is increasing worldwide, which has to be reflected by cardiovascular (CV) research in Europe. CardioScape, a FP7 funded project initiated by the European Society o...

Workforce planning and training in Obstetrics and Gynaecology across Europe: A survey of national trainee societies.

To describe the infrastructural differences in training in Obstetrics and Gynaecology (ObGyn) across Europe.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement